Amelia Kosowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amelia Kosowska has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Izabela Radzka
Student, Medical University of Wrocław, Wybrzeże Ludwika Pasteura 1, 50-367 Wrocław, Poland
2 shared publications - Jonatan Rataj
Medical University of Lodz, Poland
2 shared publications - Marlena Radzka
Medical University of Łódź, Łódź, Poland
2 shared publications - Justyna Jankowska
Medical University of Łódź, Łódź, Poland
1 shared publication - Kamil Harenza
Mikołaj Pirogow Provincial Specialist Hospital, Łódź, Poland
1 shared publication - Karolina Ollik
10th Military Clinical Hospital with Outpatient Clinic, SPZOZ, Bydgoszcz, Poland
1 shared publication
Latest Publications
- Open Access
- 21 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
CURRENT DIRECTIONS IN RESEARCH ON IRRITABLE BOWEL SYNDROME (IBS): PATHOPHYSIOLOGY, DIAGNOSIS, AND THERAPEUTIC PERSPECTIVES
This paper provides a comprehensive review of the current state of knowledge on irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, currently classified as a disorder of gut–brain interaction (DGBI). The review discusses the epidemiology, pathophysiology, clinical presentation, diagnostic approach, therapeutic management, and emerging research directions in IBS. The prevalence of IBS ranges from 3.8% to as high as 14% of the global population, with significant regional and sex-related differences. IBS is a multifactorial disorder involving disturbances of the gut–brain axis, visceral hypersensitivity, alterations in the gut microbiota (dysbiosis), immune dysfunction, as well as genetic, hormonal, and psychological factors. The clinical manifestations include recurrent abdominal pain, altered bowel habits (constipation-predominant, diarrhea-predominant, and mixed subtypes), abdominal bloating, and extraintestinal symptoms such as fatigue, sleep disturbances, anxiety, and depression. The diagnosis is based on the Rome IV criteria and the exclusion of organic diseases, particularly in the presence of alarm features ("red flags"). A multidisciplinary therapeutic approach includes patient education, dietary interventions (including the low-FODMAP and Mediterranean diets), probiotics, pharmacological treatment tailored to the IBS subtype, and psychological therapies such as cognitive behavioral therapy (CBT) and gut-directed hypnotherapy. Emerging therapeutic strategies include modulation of the gut microbiota through fecal microbiota transplantation (FMT) and next-generation probiotics, as well as mechanism-based pharmacological agents, including elobixibat and olorinab.
- 21 October 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (4(52))
Open AccessCURRENT DIRECTIONS IN RESEARCH ON IRRITABLE BOWEL SYNDROME (IBS): PATHOPHYSIOLOGY, DIAGNOSIS, AND THERAPEUTIC PERSPECTIVES
This paper provides a comprehensive review of the current state of knowledge on irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, currently classified as a disorder of gut–brain interaction (DGBI). The review discusses the epidemiology, pathophysiology, clinical presentation, diagnostic approach, therapeutic management, and emerging research directions in IBS. The prevalence of IBS ranges from 3.8% to as high as 14% of the global population, with significant regional and sex-related differences. IBS is a multifactorial disorder involving disturbances of the gut–brain axis, visceral hypersensitivity, alterations in the gut microbiota (dysbiosis), immune dysfunction, as well as genetic, hormonal, and psychological factors. The clinical manifestations include recurrent abdominal pain, altered bowel habits (constipation-predominant, diarrhea-predominant, and mixed subtypes), abdominal bloating, and extraintestinal symptoms such as fatigue, sleep disturbances, anxiety, and depression. The diagnosis is based on the Rome IV criteria and the exclusion of organic diseases, particularly in the presence of alarm features ("red flags"). A multidisciplinary therapeutic approach includes patient education, dietary interventions (including the low-FODMAP and Mediterranean diets), probiotics, pharmacological treatment tailored to the IBS subtype, and psychological therapies such as cognitive behavioral therapy (CBT) and gut-directed hypnotherapy. Emerging therapeutic strategies include modulation of the gut microbiota through fecal microbiota transplantation (FMT) and next-generation probiotics, as well as mechanism-based pharmacological agents, including elobixibat and olorinab.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
THE ROLE OF MACROPHAGES IN THE RETENTION AND TRANSFORMATION OF PIGMENT IN THE SKIN – THE IMMUNOLOGY OF TATTOOS
Tattooing involves intradermal deposition of pigment that elicits a long‑lasting immune response. Dermal macrophages play a key role in maintaining pigment by capturing pigment particles and retaining them inside their phagolysosomes. The aim of this paper is to analyze the mechanisms of phagocytosis of tattoo pigment by dermal macrophages, their impact on tattoo persistence, and to assess the significance of phenotypic differentiation (M1/M2) in the context of inflammation, laser therapy, and potential biomedical applications. We reviewed data from recent experimental studies, including 3D skin models, electron microscopy, flow cytometry, and TPE‑FLIM imaging. We also considered the effect of pigment chemical composition on activation of immune cells. Dermal macrophages demonstrate high efficiency in phagocytosis and long‑term storage of pigment. The observed “capture–release–recapture” mechanism ensures pigment stability despite natural cellular turnover. Pigment composition influences macrophage polarization (M1 or M2), which may determine chronic inflammation versus regeneration. Understanding macrophage–pigment dynamics provides new insights into tattoo durability and opens opportunities to improve the effectiveness of laser removal. Advances in imaging and the use of biosensor cells point to potential future applications of tattoos in diagnostic and regenerative medicine.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessTHE ROLE OF MACROPHAGES IN THE RETENTION AND TRANSFORMATION OF PIGMENT IN THE SKIN – THE IMMUNOLOGY OF TATTOOS
Tattooing involves intradermal deposition of pigment that elicits a long‑lasting immune response. Dermal macrophages play a key role in maintaining pigment by capturing pigment particles and retaining them inside their phagolysosomes. The aim of this paper is to analyze the mechanisms of phagocytosis of tattoo pigment by dermal macrophages, their impact on tattoo persistence, and to assess the significance of phenotypic differentiation (M1/M2) in the context of inflammation, laser therapy, and potential biomedical applications. We reviewed data from recent experimental studies, including 3D skin models, electron microscopy, flow cytometry, and TPE‑FLIM imaging. We also considered the effect of pigment chemical composition on activation of immune cells. Dermal macrophages demonstrate high efficiency in phagocytosis and long‑term storage of pigment. The observed “capture–release–recapture” mechanism ensures pigment stability despite natural cellular turnover. Pigment composition influences macrophage polarization (M1 or M2), which may determine chronic inflammation versus regeneration. Understanding macrophage–pigment dynamics provides new insights into tattoo durability and opens opportunities to improve the effectiveness of laser removal. Advances in imaging and the use of biosensor cells point to potential future applications of tattoos in diagnostic and regenerative medicine.